{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:19:06Z","timestamp":1783523946130,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["305617\/2022-2"],"award-info":[{"award-number":["305617\/2022-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005668","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Distrito Federal","doi-asserted-by":"publisher","award":["00193\\u201300001826\/2023\\u201334"],"award-info":[{"award-number":["00193\\u201300001826\/2023\\u201334"]}],"id":[{"id":"10.13039\/501100005668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005668","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Distrito Federal","doi-asserted-by":"publisher","award":["FAPDF 09\/2023"],"award-info":[{"award-number":["FAPDF 09\/2023"]}],"id":[{"id":"10.13039\/501100005668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.biopha.2025.118079","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T12:25:38Z","timestamp":1745497538000},"page":"118079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Control of aggressive 4T1-luc metastatic breast cancer using immunogenic cell lysates generated with methotrexate"],"prefix":"10.1016","volume":"187","author":[{"given":"Luana Cristina","family":"Camargo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Burgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Magalh\u00e3es","family":"Cardador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Carlos","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Letycia","family":"Rodrigues de Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Mesquita","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffael J\u00fanio","family":"Ara\u00fajo de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Martinello","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Ribeiro","family":"Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais Bergmann","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Alexandre","family":"Muehlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f4nia Nair","family":"B\u00e1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5154-7263","authenticated-orcid":false,"given":"Jo\u00e3o Paulo Figueir\u00f3","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2025.118079_bib1","first-page":"52","article-title":"Breast cancer statistics, 2013","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA: a Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118079_bib2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3389\/fonc.2020.00864","article-title":"Breast cancer survivorship, quality of life, and late toxicities","volume":"10","author":"Nardin","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2025.118079_bib3","doi-asserted-by":"crossref","DOI":"10.2174\/0113816128316870240610045550","article-title":"Doxorubicin-induced immunogenic cell death impairs tumor progression and distant metastasis in a 4T1 breast cancer tumor model","author":"Cardador","year":"2024","journal-title":"Curr. Pharm. Des."},{"issue":"15","key":"10.1016\/j.biopha.2025.118079_bib4","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.3390\/cancers14153729","article-title":"Personalised therapies for metastatic triple-negative breast cancer: when target is not everything","volume":"14","author":"Capici","year":"2022","journal-title":"Cancers"},{"issue":"28","key":"10.1016\/j.biopha.2025.118079_bib5","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2217\/nnm-2020-0201","article-title":"Combined paclitaxel-doxorubicin liposomal results in positive prognosis with infiltrating lymphocytes in lung metastasis","volume":"15","author":"de Lima","year":"2020","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2025.118079_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002927","article-title":"Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma","volume":"10","author":"Mohsen","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2025.118079_bib7","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2217\/nnm-2019-0458","article-title":"Tumor cell death in orthotopic breast cancer model by NanoALA: a novel perspective on photodynamic therapy in oncology","volume":"15","author":"de Andrade","year":"2020","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.biopha.2025.118079_bib8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1166\/jbn.2016.2208","article-title":"Prevention of distant lung metastasis after photodynamic therapy application in a breast cancer tumor model","volume":"12","author":"Longo","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"issue":"0","key":"10.1016\/j.biopha.2025.118079_bib9","article-title":"Tumor vascular heterogeneity and the impact of subtumoral nanoemulsion biodistribution","author":"de Oliveira","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2025.118079_bib10","doi-asserted-by":"crossref","DOI":"10.1039\/C8TB01577E","article-title":"Lipid nanoemulsion passive tumor accumulation dependence on tumor stage and anatomical location: a new mathematical model for in vivo imaging biodistribution study","author":"Radicchi","year":"2018","journal-title":"J. Mater. Chem. B"},{"issue":"6","key":"10.1016\/j.biopha.2025.118079_bib11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1039\/D0MD00051E","article-title":"Breast cancer: insights in disease and influence of drug methotrexate","volume":"11","author":"Yang","year":"2020","journal-title":"RSC Med. Chem."},{"issue":"15","key":"10.1016\/j.biopha.2025.118079_bib12","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2217\/nnm-2017-0091","article-title":"Acid-sensitive lipidated doxorubicin prodrug entrapped in nanoemulsion impairs lung tumor metastasis in a breast cancer model","volume":"12","author":"dos Santos C\u00e2mara","year":"2017","journal-title":"Nanomedicine"},{"issue":"11","key":"10.1016\/j.biopha.2025.118079_bib13","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jnutbio.2014.06.005","article-title":"Oil rich in carotenoids instead of vitamins C and E as a better option to reduce doxorubicin-induced damage to normal cells of Ehrlich tumor-bearing mice: hematological, toxicological and histopathological evaluations","volume":"25","author":"Miranda-Vilela","year":"2014","journal-title":"J. Nutr. Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118079_bib14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"cell"},{"issue":"1","key":"10.1016\/j.biopha.2025.118079_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/pharmaceutics14010196","article-title":"Induction of immunogenic cell death by photodynamic therapy mediated by aluminum-phthalocyanine in nanoemulsion","volume":"14","author":"Rodrigues","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.biopha.2025.118079_bib16","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3390\/pharmaceutics14081564","article-title":"An overview on immunogenic cell death in cancer biology and therapy","volume":"14","author":"Rodrigues","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10087","key":"10.1016\/j.biopha.2025.118079_bib17","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","article-title":"HER2-positive breast cancer","volume":"389","author":"Loibl","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biopha.2025.118079_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000464353","article-title":"PD-1\/PD-L1 pathway in breast cancer","volume":"40","author":"Sch\u00fctz","year":"2017","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.biopha.2025.118079_bib19","article-title":"The induction of immunogenic cell death by photodynamic therapy in B16F10 cells in vitro is affected by the concentration of the photosensitizer","author":"Vasconcelos","year":"2021","journal-title":"Photo Photodyn. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118079_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-020-00604-7","article-title":"Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells","volume":"18","author":"da Rocha","year":"2020","journal-title":"J. Nanobiotechnol."},{"issue":"23","key":"10.1016\/j.biopha.2025.118079_bib21","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1080\/17435889.2024.2382083","article-title":"Prevention of chemotherapy-related bone loss with doxorubicin-loaded solid lipid nanoparticles","volume":"19","author":"Radicchi","year":"2024","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2025.118079_bib22","article-title":"Bioluminescent imaging in a pre-clinical model of metastatic breast cancer","author":"Radicchi","year":"2025","journal-title":"J. Vis. Exp. (JoVE)"},{"key":"10.1016\/j.biopha.2025.118079_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2020.111808","article-title":"Photodynamic therapy mediated by aluminium-phthalocyanine nanoemulsion eliminates primary tumors and pulmonary metastases in a murine 4T1 breast adenocarcinoma model","author":"Rodrigues","year":"2020","journal-title":"J. Photochem. Photobiol. B: Biol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118079_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1158\/1940-6207.CAPR-17-0233","article-title":"Physical activity plus energy restriction prevents 4T1. 2 mammary tumor progression, MDSC accumulation, and an immunosuppressive tumor microenvironment","volume":"12","author":"Turbitt","year":"2019","journal-title":"Cancer Prev. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118079_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yexmp.2006.06.007","article-title":"Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors","volume":"82","author":"DuPre'","year":"2007","journal-title":"Exp. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118079_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im2002s39","article-title":"Mouse 4T1 breast tumor model","volume":"39","author":"Pulaski","year":"2000","journal-title":"Curr. Protoc. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118079_bib27","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1038\/s41598-017-07851-z","article-title":"Luciferase expression allows bioluminescence imaging but imposes limitations on the orthotopic mouse (4T1) model of breast cancer","volume":"7","author":"Baklaushev","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118079_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2016.12.012","article-title":"CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice","volume":"246","author":"Jadidi-Niaragh","year":"2017","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.biopha.2025.118079_bib29","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.3390\/cancers15082366","article-title":"Regression and eradication of triple-negative breast carcinoma in 4T1 mouse model by combination immunotherapies","volume":"15","author":"Nahar","year":"2023","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.biopha.2025.118079_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16091177","article-title":"Direct and abscopal antitumor responses elicited by AlPcNE-mediated photodynamic therapy in a murine melanoma model","volume":"16","author":"Morais","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118079_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-07469-1","article-title":"SERS investigation of cancer cells treated with PDT: quantification of cell survival and follow-up","volume":"7","author":"Veloso","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118079_bib32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s002620050504","article-title":"Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma","volume":"47","author":"Chakraborty","year":"1998","journal-title":"Cancer Immunol., Immunother."},{"issue":"15","key":"10.1016\/j.biopha.2025.118079_bib33","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2217\/nnm-2017-0091","article-title":"Acid-sensitive lipidated doxorubicin prodrug entrapped in nanoemulsion impairs lung tumor metastasis in a breast cancer model","volume":"12","author":"Camara","year":"2017","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.biopha.2025.118079_bib34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1166\/jbn.2016.2208","article-title":"Prevention of distant lung metastasis after photodynamic therapy application in a breast cancer tumor model","volume":"12","author":"Longo","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"issue":"13","key":"10.1016\/j.biopha.2025.118079_bib35","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1158\/0008-5472.CAN-08-4625","article-title":"The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression","volume":"69","author":"Ilkovitch","year":"2009","journal-title":"Cancer Res."},{"issue":"39","key":"10.1016\/j.biopha.2025.118079_bib36","doi-asserted-by":"crossref","first-page":"64505","DOI":"10.18632\/oncotarget.11352","article-title":"Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies","volume":"7","author":"Shou","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118079_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4147-6","article-title":"High CD8+\u2009and absence of Foxp3+\u2009T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival","volume":"18","author":"Flux\u00e1","year":"2018","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2025.118079_bib38","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1200\/JCO.2015.63.0970","article-title":"Prognostic effect of tumor lymphocytic infiltration in resectable non\u2013small-cell lung cancer","volume":"34","author":"Brambilla","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118079_bib39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","article-title":"Turning cold tumors hot: from molecular mechanisms to clinical applications","volume":"43","author":"Zhang","year":"2022","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118079_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+\u2009T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118079_bib41","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1073\/pnas.96.5.2233","article-title":"Immune surveillance against a solid tumor fails because of immunological ignorance","volume":"96","author":"Ochsenbein","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biopha.2025.118079_bib42","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1074-7613(02)00480-6","article-title":"Increasing tumor antigen expression overcomes \u201cignorance\u201d to solid tumors via crosspresentation by bone marrow-derived stromal cells","volume":"17","author":"Spiotto","year":"2002","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2025.118079_bib43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev-med-050217-121900","article-title":"New hope for therapeutic cancer vaccines in the era of immune checkpoint modulation","volume":"70","author":"Curran","year":"2019","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118079_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41417-020-0183-x","article-title":"Revisiting the role of CD4+\u2009T cells in cancer immunotherapy\u2014new insights into old paradigms","volume":"28","author":"Tay","year":"2021","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118079_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nm.3773","article-title":"High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+\u2009T cells in human melanoma","volume":"21","author":"Linnemann","year":"2015","journal-title":"Nat. Med."},{"issue":"7662","key":"10.1016\/j.biopha.2025.118079_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"issue":"7780","key":"10.1016\/j.biopha.2025.118079_bib47","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2025.118079_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamaoncol.2022.5143","article-title":"Safety and outcomes of a plasmid DNA vaccine encoding the ERBB2 intracellular domain in patients with advanced-stage ERBB2-positive breast cancer: a phase 1 nonrandomized clinical trial","volume":"9","author":"Disis","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.biopha.2025.118079_bib49","series-title":"Seminars in Cell & Developmental Biology","article-title":"Immunogenic cell stress and death in the treatment of cancer","author":"Pan","year":"2024"},{"issue":"3","key":"10.1016\/j.biopha.2025.118079_bib50","doi-asserted-by":"crossref","DOI":"10.4161\/onci.27878","article-title":"Trial watch: chemotherapy with immunogenic cell death inducers","volume":"3","author":"Vacchelli","year":"2014","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.biopha.2025.118079_bib51","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/ijc.32620","article-title":"CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin","volume":"145","author":"Galaine","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2025.118079_bib52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","article-title":"CD4+\u2009T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages","volume":"16","author":"DeNardo","year":"2009","journal-title":"Cancer Cell"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:29:08Z","timestamp":1778754548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":52,"alternative-id":["S0753332225002732"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118079","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Control of aggressive 4T1-luc metastatic breast cancer using immunogenic cell lysates generated with methotrexate","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118079"}}